The pharmaceutical giant Novartis is cutting up to 500 jobs at its Basel headquarters and pharmaceuticals division as part of a restructuring plan, a move that could include layoffs. The company said the job reductions were necessary to guarantee the ‘necessary resources’ for the launch of products this year.